Logo image of KRUS

KURA SUSHI USA INC-CLASS A (KRUS) Stock Fundamental Analysis

NASDAQ:KRUS - Nasdaq - US5012701026 - Common Stock - Currency: USD

86.08  +4.36 (+5.34%)

After market: 86.08 0 (0%)

Fundamental Rating

4

Overall KRUS gets a fundamental rating of 4 out of 10. We evaluated KRUS against 133 industry peers in the Hotels, Restaurants & Leisure industry. No worries on liquidiy or solvency for KRUS as it has an excellent financial health rating, but there are worries on the profitability. KRUS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

KRUS had negative earnings in the past year.
In the past year KRUS had a positive cash flow from operations.
KRUS had negative earnings in 4 of the past 5 years.
In multiple years KRUS reported negative operating cash flow during the last 5 years.
KRUS Yearly Net Income VS EBIT VS OCF VS FCFKRUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

KRUS's Return On Assets of -2.56% is on the low side compared to the rest of the industry. KRUS is outperformed by 70.68% of its industry peers.
Looking at the Return On Equity, with a value of -4.67%, KRUS is in line with its industry, outperforming 48.12% of the companies in the same industry.
Industry RankSector Rank
ROA -2.56%
ROE -4.67%
ROIC N/A
ROA(3y)-0.86%
ROA(5y)-4.62%
ROE(3y)-1.79%
ROE(5y)-10.96%
ROIC(3y)N/A
ROIC(5y)N/A
KRUS Yearly ROA, ROE, ROICKRUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

KRUS has a Gross Margin of 19.24%. This is amonst the worse of the industry: KRUS underperforms 86.47% of its industry peers.
KRUS's Gross Margin has declined in the last couple of years.
KRUS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y44.07%
GM growth 5Y-1.7%
KRUS Yearly Profit, Operating, Gross MarginsKRUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

8

2. Health

2.1 Basic Checks

KRUS does not have a ROIC to compare to the WACC, probably because it is not profitable.
KRUS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, KRUS has more shares outstanding
There is no outstanding debt for KRUS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
KRUS Yearly Shares OutstandingKRUS Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
KRUS Yearly Total Debt VS Total AssetsKRUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 3.95 indicates that KRUS is not in any danger for bankruptcy at the moment.
KRUS's Altman-Z score of 3.95 is amongst the best of the industry. KRUS outperforms 81.95% of its industry peers.
KRUS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.95
ROIC/WACCN/A
WACC8.93%
KRUS Yearly LT Debt VS Equity VS FCFKRUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 2.67 indicates that KRUS has no problem at all paying its short term obligations.
The Current ratio of KRUS (2.67) is better than 91.73% of its industry peers.
KRUS has a Quick Ratio of 2.60. This indicates that KRUS is financially healthy and has no problem in meeting its short term obligations.
KRUS has a better Quick ratio (2.60) than 91.73% of its industry peers.
Industry RankSector Rank
Current Ratio 2.67
Quick Ratio 2.6
KRUS Yearly Current Assets VS Current LiabilitesKRUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

6

3. Growth

3.1 Past

The earnings per share for KRUS have decreased strongly by -585.71% in the last year.
The Revenue has grown by 21.37% in the past year. This is a very strong growth!
Measured over the past years, KRUS shows a very strong growth in Revenue. The Revenue has been growing by 29.94% on average per year.
EPS 1Y (TTM)-585.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55.56%
Revenue 1Y (TTM)21.37%
Revenue growth 3Y54.18%
Revenue growth 5Y29.94%
Sales Q2Q%13.27%

3.2 Future

The Earnings Per Share is expected to grow by 25.31% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 18.70% on average over the next years. This is quite good.
EPS Next Y70.26%
EPS Next 2Y45.29%
EPS Next 3Y34.47%
EPS Next 5Y25.31%
Revenue Next Year18.06%
Revenue Next 2Y18.35%
Revenue Next 3Y19.19%
Revenue Next 5Y18.7%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
KRUS Yearly Revenue VS EstimatesKRUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
KRUS Yearly EPS VS EstimatesKRUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 2 -2

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KRUS. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 1063.14, KRUS can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of KRUS indicates a slightly more expensive valuation: KRUS is more expensive than 72.18% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.60. KRUS is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 1063.14
KRUS Price Earnings VS Forward Price EarningsKRUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 400 600 800 1K

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, KRUS is valued expensively inside the industry as 84.21% of the companies are valued cheaper.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 629.47
KRUS Per share dataKRUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates KRUS does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as KRUS's earnings are expected to grow with 34.47% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.29%
EPS Next 3Y34.47%

0

5. Dividend

5.1 Amount

No dividends for KRUS!.
Industry RankSector Rank
Dividend Yield N/A

KURA SUSHI USA INC-CLASS A

NASDAQ:KRUS (6/30/2025, 8:26:30 PM)

After market: 86.08 0 (0%)

86.08

+4.36 (+5.34%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)04-08 2025-04-08/amc
Earnings (Next)07-08 2025-07-08/amc
Inst Owners74.05%
Inst Owner Change-3.71%
Ins Owners6.83%
Ins Owner Change1.1%
Market Cap1.04B
Analysts78.75
Price Target78.99 (-8.24%)
Short Float %27.09%
Short Ratio5.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)28.17%
Min EPS beat(2)-5.58%
Max EPS beat(2)61.93%
EPS beat(4)1
Avg EPS beat(4)-6629.19%
Min EPS beat(4)-26473.1%
Max EPS beat(4)61.93%
EPS beat(8)3
Avg EPS beat(8)-3341.92%
EPS beat(12)6
Avg EPS beat(12)-2194.36%
EPS beat(16)10
Avg EPS beat(16)-1641.39%
Revenue beat(2)1
Avg Revenue beat(2)0.2%
Min Revenue beat(2)-1.99%
Max Revenue beat(2)2.38%
Revenue beat(4)2
Avg Revenue beat(4)-0.2%
Min Revenue beat(4)-1.99%
Max Revenue beat(4)2.38%
Revenue beat(8)2
Avg Revenue beat(8)-1.23%
Revenue beat(12)4
Avg Revenue beat(12)-0.56%
Revenue beat(16)7
Avg Revenue beat(16)1.21%
PT rev (1m)18.14%
PT rev (3m)-28.66%
EPS NQ rev (1m)-207.14%
EPS NQ rev (3m)-116.45%
EPS NY rev (1m)13.37%
EPS NY rev (3m)-381.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.48%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-1.19%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1063.14
P/S 4.03
P/FCF N/A
P/OCF 57.76
P/B 4.62
P/tB 4.62
EV/EBITDA 629.47
EPS(TTM)-0.68
EYN/A
EPS(NY)0.08
Fwd EY0.09%
FCF(TTM)-2.28
FCFYN/A
OCF(TTM)1.49
OCFY1.73%
SpS21.38
BVpS18.61
TBVpS18.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.56%
ROE -4.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.24%
FCFM N/A
ROA(3y)-0.86%
ROA(5y)-4.62%
ROE(3y)-1.79%
ROE(5y)-10.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y44.07%
GM growth 5Y-1.7%
F-Score4
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 350.42%
Cap/Sales 17.63%
Interest Coverage N/A
Cash Conversion 1186.89%
Profit Quality N/A
Current Ratio 2.67
Quick Ratio 2.6
Altman-Z 3.95
F-Score4
WACC8.93%
ROIC/WACCN/A
Cap/Depr(3y)464%
Cap/Depr(5y)432.88%
Cap/Sales(3y)20.03%
Cap/Sales(5y)22.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-585.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55.56%
EPS Next Y70.26%
EPS Next 2Y45.29%
EPS Next 3Y34.47%
EPS Next 5Y25.31%
Revenue 1Y (TTM)21.37%
Revenue growth 3Y54.18%
Revenue growth 5Y29.94%
Sales Q2Q%13.27%
Revenue Next Year18.06%
Revenue Next 2Y18.35%
Revenue Next 3Y19.19%
Revenue Next 5Y18.7%
EBIT growth 1Y-1058.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year394.88%
EBIT Next 3Y94.97%
EBIT Next 5Y59.42%
FCF growth 1Y-92.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.12%
OCF growth 3YN/A
OCF growth 5Y21.12%